These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20859891)

  • 1. [Hypercholesterolemia as important as glycemic control in patients with myocardial infarction and diabetes].
    Siudak Z; Dudek D
    Kardiol Pol; 2010 Sep; 68(9):1013-4. PubMed ID: 20859891
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between low-density lipoprotein cholesterol level on admission and in-hospital mortality in patients with ST-segment elevation myocardial infarction, with or without diabetes, treated with percutaneous coronary intervention.
    Pres D; Gasior M; Lekston A; Gierlotka M; Hawranek M; Tajstra M; Buchta P; Słonka G; Poloński L
    Kardiol Pol; 2010 Sep; 68(9):1005-12. PubMed ID: 20859890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type 2 diabetic: risk same as after infarct. With LDL not only the quantity counts].
    MMW Fortschr Med; 2004 Jun; 146(24):4. PubMed ID: 15366509
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypercholesterolemia in high risk patients. Targeting low goal values].
    MMW Fortschr Med; 2001 Apr; 143(15):50-1. PubMed ID: 11349323
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels].
    Laufs U
    Dtsch Med Wochenschr; 2012 Oct; 137(43):2200. PubMed ID: 23076665
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated guidelines support even lower cholesterol levels for at-risk patients.
    Levenson D
    Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
    [No Abstract]   [Full Text] [Related]  

  • 11. [Consequences of the "A to Z" studies: Cholesterol in acute coronary syndrome early and aggressive reduction?].
    März W
    Herz; 2005 Feb; 30(1):78-80. PubMed ID: 16167397
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke.
    Muntner P; DeSalvo KB; Wildman RP; Raggi P; He J; Whelton PK
    Am J Epidemiol; 2006 May; 163(10):913-20. PubMed ID: 16597707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["No infarct without elevated LDL cholesterol"!].
    Greten H
    MMW Fortschr Med; 2008 Nov; 150(48):119. PubMed ID: 19125517
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulating LDL cholesterol and glucose in patients with type 2 diabetes mellitus: targeting the bile acid pathway.
    Goldfine AB
    Curr Opin Cardiol; 2008 Sep; 23(5):502-11. PubMed ID: 18670263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meet the cholesterol busters.
    Healy B
    US News World Rep; 2004 Mar 22-29; 136(10):54. PubMed ID: 15069903
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventing infarct by lowering LDL. Is 100 the upper limit for every diabetic patient?].
    MMW Fortschr Med; 2003 Sep; 145(38):60. PubMed ID: 14603687
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Good prevention of type 2 diabetes with lipid-lowering statin therapy. Intervention studies support active treatment of risk patients].
    Nilsson PM; Attvall S; Båvenholm P
    Lakartidningen; 2004 Nov; 101(47):3798, 3801-2, 3804. PubMed ID: 15609534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Risk patients are often insufficiently treated. LDL cholesterol to be held down even more vigorously].
    MMW Fortschr Med; 2004 Oct; 146(44):56-7. PubMed ID: 15566253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.